Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention

Spartalis, Michael; Tzatzaki, Eleni; Nikiteas, Nikolaos I.; Spartalis, Eleftherios

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/4Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes

In titles and abstracts

In keywords

In all

The Anatolian Journal of Cardiology

Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention [Anatol J Cardiol]

Anatol J Cardiol. 2017; 18(5): 376-377 | DOI: 10.14744/AnatolJCardiol.2017.8009

Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention

Michael Spartalis¹, Eleni Tzatzaki¹, Nikolaos I. Nikiteas², Eleftherios Spartalis²
¹Division of Cardiology, Onassis Cardiac Surgery Center, Athens-Greece
²Laboratory of Experimental Surgery and Surgical Research, University of Athens Medical School, Athens-Greece

Michael Spartalis, Eleni Tzatzaki, Nikolaos I. Nikiteas, Eleftherios Spartalis. Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention. Anatol J Cardiol. 2017; 18(5): 376-377

Corresponding Author: Michael Spartalis, Greece
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar